Skip to main content
. Author manuscript; available in PMC: 2017 Jan 27.
Published in final edited form as: Small. 2015 Dec 7;12(4):477–487. doi: 10.1002/smll.201501985

Figure 6.

Figure 6

Evaluation of tumor uptake of NP-siRNA-GPC3 Ab in vivo. (a) Xenogen IVIS images showing co-localization of RH7777-Luc-GPC3 tumor and Dy677-labeled siRNA loaded NP at different time points post-injection from one untreated and two treated mice. (b) Confocal fluorescence microscopy images showing accumulation of NP-siRNA-GPC3 Ab in tumor sections at 120 hr after injection from the same animals presented in panel (a).